Growing Your Business With Supplements
When looking to grow business with supplement sales, pharmacists should first educate themselves.
Prepare for Allergy Season
Relieving symptoms and optimizing therapies for allergic rhinitis
NCPA, NACDS Underscore Role of Community Pharmacists in Fighting COVID-19
President Trump's coronavirus task force urged to tap into the potential of community pharmacies in combatting the coronavirus pandemic.
Making A Career Pivot
Pharmacy managers and educators offer career advice.
Ubrogepant: A Novel Drug Mechanism for Migraine Treatment
On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.
Pharmacies Brace for Increased Refills Due to Coronavirus
Insurers, physicians, and others are advising patients with chronic conditions to ensure they have more than enough medication on hand.
Study Links Conscientious Vaccine Exemptions in Texas with Certain Demographics
A new study identified demographics that characterize a higher risk of conscientious vaccination exemptions for children in Texas.
Clinical Trials of Sarilumab to Treat Severe COVID-19 Set to Begin in the US
Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.
Flattening the COVID-19 Curve: President Trump's Plan to Slow the Spread
President Trump and his health advisors announced a 15-day plan to slow the spread of COVID-19.
FDA Grants Fast Track Designation to Empagliflozin for Chronic Kidney Disease
Empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) is being investigated to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease.
Clinical Trial Launched for Investigational COVID-19 Vaccine
A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.
What Pharmacists Should Know About Multiple Sclerosis
Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.
Telehealth Services, Online Resources Aim to Enhance Health Care Amid COVID-19 Pandemic
Telehealth advancements in response to COVID-19 reveal the importance of digital health delivery during outbreaks.
Pharmacy Chains, Other Retailers to Offer COVID-19 Testing
Walgreens, CVS Health, and Target said they will start providing coronavirus disease (COVID-19) testing in their parking lots.
Going Beyond Dispensing: The Future of Pharmacist Roles
Walk into a pharmacy in 2030 and there’s a good chance you’ll see a pharmacist. And there’s a good chance the pharmacist will have little or nothing to do with dispensing.
COVID-19 Update: Pharmacy Meetings Cancelled, New Law Expands Florida Pharmacists’ Roles
An update on how COVID-19 is affecting pharmacy.
More Than One-Third Of US Children Not Following Recommended Vaccine Schedule, Study Finds
More than one-third of all children in the United States are not following the recommended vaccine schedule, according to a new study.
New Study Examines Why Some Fare Better with the Flu Than Others
A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.
Study Finds Habitual Fish Oil Use Linked to Cardiovascular Benefits
Fish oil supplementation may be associated with lower all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events.
Drug Shortages Act Needed As Coronavirus Threats Grow
COVID-19 Officially Declared a Pandemic by WHO
The World Health Organization declared the novel coronavirus outbreak a pandemic.
FDA Approves Pizensy for Treatment of Chronic Idiopathic Constipation in Adults
EHR Data Analysis Suggests Need for Improvement in Blood Pressure Management
A new study found several shortcomings in blood pressure management.
CROI 2020: New Data Comparing Descovy, Truvada for HIV PrEP
At the 2020 Conference on Retroviruses and Opportunistic Infections (CROI), longer-term study results on emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for HIV PrEP were presented.
CVS Pharmacy Acquires Schnucks Pharmacies, 11 Will Close
Eleven Schnuck Markets’ pharmacies will close after CVS Pharmacy’s acquisition of 110 Schnuck’s pharmacies.
FDA OKs Nintedanib for Progressive Interstitial Lung Diseases
Nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) has been approved for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype.
Opioid Overdose Deaths Decreasing
Combating the opioid epidemic is a popular cause, and many organizations, government entities, and health care groups have responded.
CVS Reacts After Pharmacist Tests Positive for Coronavirus
The Warren County Health Department informed CVS Health that patients are considered to be at low risk, but is still taking precautions.
President Trump Signs Coronavirus Bill as Pharmacies Show Their Value in Outbreak
President Donald Trump has signed a bill that will provide more than $8.3 billion to fight the coronavirus disease outbreak.
6 Ways to Diversify Your Pharmacy's Revenue Streams
Strategies for seizing revenue opportunities outside of the PBM.